Post-acquisitions cost"Post-acquisition Nova Leap’s strategy is to enhance all businesses and increase Adjusted EBITDA through the following:
• Enhancement of sales and marketing strategies;
• Implementation of efficiencies around payroll, scheduling, billing, accounting and human capital;
•Increased investment in staff and staff training;
• Expansion of services, partnerships and geographical coverage;
• In-State and In-Province organic expansion by increased office location footprint; and
• Enhancement of risk management policies."
Numbers and text from Year end financial statement: https://novaleaphealth.com/financial-statements/
This will weigh on the balance sheet in the short term, as we now see, but bring in increased income in the long term. The CEO has previously compared with Amedisys in some respects. For them, it took a long time before they showed strong figures in EBITDA when they invested in rapid growth with a different focus.